NCT03525561View on ClinicalTrials.gov

Acetazolamide and Exercise Performance at Altitude

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 10, 2018

Primary Completion Date

May 15, 2019

Study Completion Date

May 15, 2019

Conditions
HypoxiaExercise PerformanceCognitive FunctionDexterity
Interventions
DRUG

Acetazolamide Pill

Subjects will take acetazolamide pill (Diamox), 500 mg/ day, and assess effect on exercise performance during 30-hour exposure to 3,500 m simulated altitude.

DRUG

Placebo pill

Subjects will take placebo pill and then we will assess exercise performance during 30-hour exposure to 3,500 m simulated altitude.

Trial Locations (1)

01760

Natick Soldier Systems Center, Natick

All Listed Sponsors
lead

United States Army Research Institute of Environmental Medicine

FED

NCT03525561 - Acetazolamide and Exercise Performance at Altitude | Biotech Hunter | Biotech Hunter